Nicolas Azzopardi
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Inhalation and Respiratory Drug Delivery 3
- Oncology 8
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 6
- Co-authors
- Gilles Paintaud (21 shared papers)David Ternant (14 shared papers)Valérie Gouilleux‐Gruart (9 shared papers)Thierry Lecomte (6 shared papers)Hervé Watier (5 shared papers)Nathalie Heuzé‐Vourc'h (5 shared papers)Érick Gamelin (3 shared papers)J. Montharu (3 shared papers)
- Journals
- Clinical Pharmacokinetics (6 papers)mAbs (3 papers)British Journal of Clinical Pharmacology (2 papers)Therapeutic Drug Monitoring (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- FranceUnited StatesPoland
In The Last Decade
Nicolas Azzopardi
23 papers receiving 614 citations
Peers
Comparison fields: 5 of 78
- Radiology, Nuclear Medicine and Imaging 205
- Genetics 92
- Immunology 159
- Oncology 182
- Pulmonary and Respiratory Medicine 215
Countries citing papers authored by Nicolas Azzopardi
This map shows the geographic impact of Nicolas Azzopardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Azzopardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Azzopardi more than expected).
Fields of papers citing papers by Nicolas Azzopardi
This network shows the impact of papers produced by Nicolas Azzopardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Azzopardi. The network helps show where Nicolas Azzopardi may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Azzopardi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 95 | |
| 2 | 2011 | 80 | |
| 3 | 2011 | 64 | |
| 4 | 2013 | 56 | |
| 5 | 2009 | 53 | |
| 6 | 2016 | 49 | |
| 7 | 2014 | 31 | |
| 8 | 2018 | 28 | |
| 9 | 2019 | 26 | |
| 10 | 2016 | 22 | |
| 11 | 2016 | 21 | |
| 12 | 2017 | 18 | |
| 13 | 2015 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 14 | |
| 16 | 2021 | 13 | |
| 17 | 2021 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2024 | 4 | |
| 20 | 2015 | 4 |
About Nicolas Azzopardi
Nicolas Azzopardi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Molecular Biology, having authored 24 papers that have together received 625 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Inhalation and Respiratory Drug Delivery (3 papers), Protein purification and stability (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (205 citations), Genetics (92 citations), Immunology (159 citations), Oncology (182 citations) and Pulmonary and Respiratory Medicine (215 citations). Nicolas Azzopardi has collaborated with scholars based in France, United States and Poland. Frequent co-authors include Gilles Paintaud, David Ternant, Valérie Gouilleux‐Gruart, Thierry Lecomte, Hervé Watier, Nathalie Heuzé‐Vourc'h, Érick Gamelin, J. Montharu, Laurent Guilleminault and P. Diot. Their work appears in journals such as Clinical Pharmacokinetics, mAbs, British Journal of Clinical Pharmacology, Therapeutic Drug Monitoring and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.